デフォルト表紙
市場調査レポート
商品コード
1403487

臓器保存ソリューション市場の2030年までの予測:ソリューション別、保存タイプ別、臓器別、エンドユーザー別、地域別の世界分析

Organ Preservation Solution Market Forecasts to 2030 - Global Analysis By Solution, Preservation Type, Organ, End User and by Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
臓器保存ソリューション市場の2030年までの予測:ソリューション別、保存タイプ別、臓器別、エンドユーザー別、地域別の世界分析
出版日: 2024年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、世界の臓器保存ソリューション市場は2023年に2億7,864万米ドルを占め、予測期間中にCAGR 8.8%で成長し、2030年には5億285万米ドルに達すると予測されています。

臓器保存ソリューションは、臓器提供から移植までの重要な期間に臓器の生存能力を維持する能力を有しており、臓器保存ソリューションは移植医療に不可欠です。理想的な保存環境は、虚血ダメージから臓器を保護するために作られたこれらの特殊なソリューションによって提供されます。これらの溶液は、細胞の完全性を保ち、細胞の膨張を防ぐのに役立ちます。

米国疾病予防管理センター(CDC)の2020年の推計によると、糖尿病の成人の3人に1人、高血圧の成人の5人に1人が慢性腎臓病に罹患している可能性があります。2021年に発表されたCDCの報告書によると、米国では毎年15%の人が慢性腎臓病を患っています。

臓器移植手術の増加

臓器不全を引き起こす慢性疾患の増加に加え、手術方法や免疫抑制剤の改善により、世界の臓器移植率はとどまるところを知らない勢いで増加しています。さらに、需要の高まりは、臓器保存ソリューションが移植手術の生存と成功にいかに不可欠であるかを浮き彫りにしており、その結果、さまざまな種類の臓器に対応するこれらのソリューションを強化・最適化するための研究開発が進められています。

既存の保存方法の有効性の限界

臓器によっては、現在の臓器保存法では、この分野の進歩があっても、特に長期間保存した場合に、その生存率が制限される場合があります。様々な臓器が複雑であり、その生理学的要件も異なるため、普遍的に有効な解決策を開発することは困難です。さらに、各臓器に特有の保存要件を包括的に把握し、現行の製剤の有効性を改善するための継続的な調査が、この制約に対処するために必要です。

凍結保存の技術開発

凍結保存技術が進歩し続ける限り、臓器保存市場は成長すると予想されます。凍結保護剤と凍結技術の進歩により、臓器保存期間の延長と長期保存の実現性の向上が可能になります。さらに、これはより柔軟な臓器移植のスケジューリングと物流管理の改善につながります。

保存手順の不十分な標準化

臓器保存の手順が確立されていないことが、この業界に障害とリスクをもたらしています。ヘルスケア施設や地域によってプロトコルが異なっていると、コミュニケーションが妨げられ、保存結果に一貫性がなくなる可能性があります。さらに、臓器保存技術の信頼性と効率を保証するためには、広く認知された基準の確立が不可欠です。

COVID-19の影響:

臓器保存の市場は、COVID-19の大流行からさまざまな影響を受けています。臓器移植手術が影響を受け、その結果、移植件数が減少しています。これらの要因には、ヘルスケアシステムの混乱、物流の困難、パンデミック管理への優先順位のシフトなどが含まれます。臓器移植は、閉鎖、旅行制限、ヘルスケアへのアクセス制限によって妨げられてきました。さらに、臓器保存のための研究開発も、ヘルスケアの予算や資源に対する財政的な負担に応じて変化しています。

予測期間中、ウィスコンシン大学ソリューション(UW)セグメントが最大になる見込み

ウィスコンシン大学ソリューション(UW)セグメントが最大の市場シェアを占めると予測されます。腎臓、肝臓、膵臓の臓器移植は、非常に効果的で適応性の高い臓器保存培地であるUW溶液を用いて頻繁に行われています。その浸透圧、バランスのとれた電解質組成、細胞浮腫を軽減する能力から、臓器調達から移植までの間の重要な時期に、臓器保存の選択肢として推奨されています。さらに、この製品が広く受け入れられているのは、移植の成功例、臨床使用の長い歴史、臓器の生存能力保持の実績によるものです。

予測期間中にCAGRが最も高くなると予想される専門クリニック分野

臓器保存市場は、専門クリニックにおいて最も高いCAGRで成長しています。臓器移植と臓器保存に特化した専門クリニックの成長は、より専門的なヘルスケアサービスを求める動向と、的を絞った患者中心のケアに対するニーズの高まりによって促進されています。移植前の評価、臓器保存技術、移植後のケアは、これらのクリニックが提供する広範なサービスのほんの一部に過ぎないです。さらに、臓器不全の有病率の増加や移植技術の進歩により、患者は従来の病院よりも効率的で個別化されたケアを提供することが多い専門クリニックの専門知識を求めています。

最もシェアの高い地域:

臓器保存ソリューション市場では、北米が最大のシェアを占めています。この優位性には、整備されたヘルスケアシステム、臓器移植の頻度の高さ、医学と技術の進歩など、数多くの要因が寄与しています。さらに、同地域は強力な規制環境、大規模な研究開発費、最先端のヘルスケアソリューションの積極的な採用により、業界の最先端を走っています。

CAGRが最も高い地域:

臓器保存ソリューション市場では、アジア太平洋地域のCAGRが最も高いです。臓器不全の有病率の増加、臓器移植に対する社会の認識、ヘルスケアインフラの進歩など、多くの要因がこの地域の急成長を後押ししています。さらに、アジア太平洋地域における市場シェアの拡大は、臓器保存技術の進歩だけでなく、医療ツーリズムが重視されるようになっていることにも起因しています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます:

  • 企業プロファイル
    • 追加市場企業の包括的プロファイリング(3社まで)
    • 主要企業のSWOT分析(3社まで)
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR(注:フィージビリティチェックによる)
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症(COVID-19)の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の臓器保存ソリューション市場:ソリューション別

  • ウィスコンシン大学ソリューション(UW)
  • カストジオールHTKソリューション
  • パーファデックスソリューション
  • スティーンソリューション
  • セルシオソリューション
  • 低体温ソリューション
  • その他のソリューション

第6章 世界の臓器保存ソリューション市場:保存タイプ別

  • 静的冷蔵保管
  • 低体温マシン灌流
  • 正常温マシン灌流
  • その他の保存タイプ

第7章 世界の臓器保存ソリューション市場:臓器別

  • 腎臓
  • 肝臓
  • 心臓
  • その他の臓器

第8章 世界の臓器保存ソリューション市場:エンドユーザー別

  • 臓器移植センター
  • 病院
  • 専門クリニック
  • その他のエンドユーザー

第9章 世界の臓器保存ソリューション市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他のアジア太平洋
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他の南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他の中東・アフリカ

第10章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第11章 企業プロファイル

  • Paragonix Technologies, Inc
  • Organox Limited
  • Transmedics, Inc.
  • Bridge to Life Ltd
  • Transplant Biomedicals
  • Accord Healthcare Inc.
  • Waters Medical Systems LLC
  • Preservation Solutions, Inc.
  • Xvivo Perfusion AB
図表

List of Tables

  • Table 1 Global Organ Preservation Solution Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Organ Preservation Solution Market Outlook, By Solution (2021-2030) ($MN)
  • Table 3 Global Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2021-2030) ($MN)
  • Table 4 Global Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2021-2030) ($MN)
  • Table 5 Global Organ Preservation Solution Market Outlook, By Perfadex Solution (2021-2030) ($MN)
  • Table 6 Global Organ Preservation Solution Market Outlook, By Steen Solution (2021-2030) ($MN)
  • Table 7 Global Organ Preservation Solution Market Outlook, By Celsior Solution (2021-2030) ($MN)
  • Table 8 Global Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2021-2030) ($MN)
  • Table 9 Global Organ Preservation Solution Market Outlook, By Other Solutions (2021-2030) ($MN)
  • Table 10 Global Organ Preservation Solution Market Outlook, By Preservation Type (2021-2030) ($MN)
  • Table 11 Global Organ Preservation Solution Market Outlook, By Static Cold Storage (2021-2030) ($MN)
  • Table 12 Global Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2021-2030) ($MN)
  • Table 13 Global Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2021-2030) ($MN)
  • Table 14 Global Organ Preservation Solution Market Outlook, By Other Preservation Types (2021-2030) ($MN)
  • Table 15 Global Organ Preservation Solution Market Outlook, By Organ (2021-2030) ($MN)
  • Table 16 Global Organ Preservation Solution Market Outlook, By Kidneys (2021-2030) ($MN)
  • Table 17 Global Organ Preservation Solution Market Outlook, By Liver (2021-2030) ($MN)
  • Table 18 Global Organ Preservation Solution Market Outlook, By Lungs (2021-2030) ($MN)
  • Table 19 Global Organ Preservation Solution Market Outlook, By Heart (2021-2030) ($MN)
  • Table 20 Global Organ Preservation Solution Market Outlook, By Other Organs (2021-2030) ($MN)
  • Table 21 Global Organ Preservation Solution Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2021-2030) ($MN)
  • Table 23 Global Organ Preservation Solution Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 Global Organ Preservation Solution Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 25 Global Organ Preservation Solution Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 26 North America Organ Preservation Solution Market Outlook, By Country (2021-2030) ($MN)
  • Table 27 North America Organ Preservation Solution Market Outlook, By Solution (2021-2030) ($MN)
  • Table 28 North America Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2021-2030) ($MN)
  • Table 29 North America Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2021-2030) ($MN)
  • Table 30 North America Organ Preservation Solution Market Outlook, By Perfadex Solution (2021-2030) ($MN)
  • Table 31 North America Organ Preservation Solution Market Outlook, By Steen Solution (2021-2030) ($MN)
  • Table 32 North America Organ Preservation Solution Market Outlook, By Celsior Solution (2021-2030) ($MN)
  • Table 33 North America Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2021-2030) ($MN)
  • Table 34 North America Organ Preservation Solution Market Outlook, By Other Solutions (2021-2030) ($MN)
  • Table 35 North America Organ Preservation Solution Market Outlook, By Preservation Type (2021-2030) ($MN)
  • Table 36 North America Organ Preservation Solution Market Outlook, By Static Cold Storage (2021-2030) ($MN)
  • Table 37 North America Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2021-2030) ($MN)
  • Table 38 North America Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2021-2030) ($MN)
  • Table 39 North America Organ Preservation Solution Market Outlook, By Other Preservation Types (2021-2030) ($MN)
  • Table 40 North America Organ Preservation Solution Market Outlook, By Organ (2021-2030) ($MN)
  • Table 41 North America Organ Preservation Solution Market Outlook, By Kidneys (2021-2030) ($MN)
  • Table 42 North America Organ Preservation Solution Market Outlook, By Liver (2021-2030) ($MN)
  • Table 43 North America Organ Preservation Solution Market Outlook, By Lungs (2021-2030) ($MN)
  • Table 44 North America Organ Preservation Solution Market Outlook, By Heart (2021-2030) ($MN)
  • Table 45 North America Organ Preservation Solution Market Outlook, By Other Organs (2021-2030) ($MN)
  • Table 46 North America Organ Preservation Solution Market Outlook, By End User (2021-2030) ($MN)
  • Table 47 North America Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2021-2030) ($MN)
  • Table 48 North America Organ Preservation Solution Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 49 North America Organ Preservation Solution Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 50 North America Organ Preservation Solution Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 51 Europe Organ Preservation Solution Market Outlook, By Country (2021-2030) ($MN)
  • Table 52 Europe Organ Preservation Solution Market Outlook, By Solution (2021-2030) ($MN)
  • Table 53 Europe Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2021-2030) ($MN)
  • Table 54 Europe Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2021-2030) ($MN)
  • Table 55 Europe Organ Preservation Solution Market Outlook, By Perfadex Solution (2021-2030) ($MN)
  • Table 56 Europe Organ Preservation Solution Market Outlook, By Steen Solution (2021-2030) ($MN)
  • Table 57 Europe Organ Preservation Solution Market Outlook, By Celsior Solution (2021-2030) ($MN)
  • Table 58 Europe Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2021-2030) ($MN)
  • Table 59 Europe Organ Preservation Solution Market Outlook, By Other Solutions (2021-2030) ($MN)
  • Table 60 Europe Organ Preservation Solution Market Outlook, By Preservation Type (2021-2030) ($MN)
  • Table 61 Europe Organ Preservation Solution Market Outlook, By Static Cold Storage (2021-2030) ($MN)
  • Table 62 Europe Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2021-2030) ($MN)
  • Table 63 Europe Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2021-2030) ($MN)
  • Table 64 Europe Organ Preservation Solution Market Outlook, By Other Preservation Types (2021-2030) ($MN)
  • Table 65 Europe Organ Preservation Solution Market Outlook, By Organ (2021-2030) ($MN)
  • Table 66 Europe Organ Preservation Solution Market Outlook, By Kidneys (2021-2030) ($MN)
  • Table 67 Europe Organ Preservation Solution Market Outlook, By Liver (2021-2030) ($MN)
  • Table 68 Europe Organ Preservation Solution Market Outlook, By Lungs (2021-2030) ($MN)
  • Table 69 Europe Organ Preservation Solution Market Outlook, By Heart (2021-2030) ($MN)
  • Table 70 Europe Organ Preservation Solution Market Outlook, By Other Organs (2021-2030) ($MN)
  • Table 71 Europe Organ Preservation Solution Market Outlook, By End User (2021-2030) ($MN)
  • Table 72 Europe Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2021-2030) ($MN)
  • Table 73 Europe Organ Preservation Solution Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 74 Europe Organ Preservation Solution Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 75 Europe Organ Preservation Solution Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 76 Asia Pacific Organ Preservation Solution Market Outlook, By Country (2021-2030) ($MN)
  • Table 77 Asia Pacific Organ Preservation Solution Market Outlook, By Solution (2021-2030) ($MN)
  • Table 78 Asia Pacific Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2021-2030) ($MN)
  • Table 79 Asia Pacific Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2021-2030) ($MN)
  • Table 80 Asia Pacific Organ Preservation Solution Market Outlook, By Perfadex Solution (2021-2030) ($MN)
  • Table 81 Asia Pacific Organ Preservation Solution Market Outlook, By Steen Solution (2021-2030) ($MN)
  • Table 82 Asia Pacific Organ Preservation Solution Market Outlook, By Celsior Solution (2021-2030) ($MN)
  • Table 83 Asia Pacific Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2021-2030) ($MN)
  • Table 84 Asia Pacific Organ Preservation Solution Market Outlook, By Other Solutions (2021-2030) ($MN)
  • Table 85 Asia Pacific Organ Preservation Solution Market Outlook, By Preservation Type (2021-2030) ($MN)
  • Table 86 Asia Pacific Organ Preservation Solution Market Outlook, By Static Cold Storage (2021-2030) ($MN)
  • Table 87 Asia Pacific Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2021-2030) ($MN)
  • Table 88 Asia Pacific Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2021-2030) ($MN)
  • Table 89 Asia Pacific Organ Preservation Solution Market Outlook, By Other Preservation Types (2021-2030) ($MN)
  • Table 90 Asia Pacific Organ Preservation Solution Market Outlook, By Organ (2021-2030) ($MN)
  • Table 91 Asia Pacific Organ Preservation Solution Market Outlook, By Kidneys (2021-2030) ($MN)
  • Table 92 Asia Pacific Organ Preservation Solution Market Outlook, By Liver (2021-2030) ($MN)
  • Table 93 Asia Pacific Organ Preservation Solution Market Outlook, By Lungs (2021-2030) ($MN)
  • Table 94 Asia Pacific Organ Preservation Solution Market Outlook, By Heart (2021-2030) ($MN)
  • Table 95 Asia Pacific Organ Preservation Solution Market Outlook, By Other Organs (2021-2030) ($MN)
  • Table 96 Asia Pacific Organ Preservation Solution Market Outlook, By End User (2021-2030) ($MN)
  • Table 97 Asia Pacific Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2021-2030) ($MN)
  • Table 98 Asia Pacific Organ Preservation Solution Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 99 Asia Pacific Organ Preservation Solution Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 100 Asia Pacific Organ Preservation Solution Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 South America Organ Preservation Solution Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 South America Organ Preservation Solution Market Outlook, By Solution (2021-2030) ($MN)
  • Table 103 South America Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2021-2030) ($MN)
  • Table 104 South America Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2021-2030) ($MN)
  • Table 105 South America Organ Preservation Solution Market Outlook, By Perfadex Solution (2021-2030) ($MN)
  • Table 106 South America Organ Preservation Solution Market Outlook, By Steen Solution (2021-2030) ($MN)
  • Table 107 South America Organ Preservation Solution Market Outlook, By Celsior Solution (2021-2030) ($MN)
  • Table 108 South America Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2021-2030) ($MN)
  • Table 109 South America Organ Preservation Solution Market Outlook, By Other Solutions (2021-2030) ($MN)
  • Table 110 South America Organ Preservation Solution Market Outlook, By Preservation Type (2021-2030) ($MN)
  • Table 111 South America Organ Preservation Solution Market Outlook, By Static Cold Storage (2021-2030) ($MN)
  • Table 112 South America Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2021-2030) ($MN)
  • Table 113 South America Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2021-2030) ($MN)
  • Table 114 South America Organ Preservation Solution Market Outlook, By Other Preservation Types (2021-2030) ($MN)
  • Table 115 South America Organ Preservation Solution Market Outlook, By Organ (2021-2030) ($MN)
  • Table 116 South America Organ Preservation Solution Market Outlook, By Kidneys (2021-2030) ($MN)
  • Table 117 South America Organ Preservation Solution Market Outlook, By Liver (2021-2030) ($MN)
  • Table 118 South America Organ Preservation Solution Market Outlook, By Lungs (2021-2030) ($MN)
  • Table 119 South America Organ Preservation Solution Market Outlook, By Heart (2021-2030) ($MN)
  • Table 120 South America Organ Preservation Solution Market Outlook, By Other Organs (2021-2030) ($MN)
  • Table 121 South America Organ Preservation Solution Market Outlook, By End User (2021-2030) ($MN)
  • Table 122 South America Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2021-2030) ($MN)
  • Table 123 South America Organ Preservation Solution Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 124 South America Organ Preservation Solution Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 125 South America Organ Preservation Solution Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 126 Middle East & Africa Organ Preservation Solution Market Outlook, By Country (2021-2030) ($MN)
  • Table 127 Middle East & Africa Organ Preservation Solution Market Outlook, By Solution (2021-2030) ($MN)
  • Table 128 Middle East & Africa Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2021-2030) ($MN)
  • Table 129 Middle East & Africa Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2021-2030) ($MN)
  • Table 130 Middle East & Africa Organ Preservation Solution Market Outlook, By Perfadex Solution (2021-2030) ($MN)
  • Table 131 Middle East & Africa Organ Preservation Solution Market Outlook, By Steen Solution (2021-2030) ($MN)
  • Table 132 Middle East & Africa Organ Preservation Solution Market Outlook, By Celsior Solution (2021-2030) ($MN)
  • Table 133 Middle East & Africa Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2021-2030) ($MN)
  • Table 134 Middle East & Africa Organ Preservation Solution Market Outlook, By Other Solutions (2021-2030) ($MN)
  • Table 135 Middle East & Africa Organ Preservation Solution Market Outlook, By Preservation Type (2021-2030) ($MN)
  • Table 136 Middle East & Africa Organ Preservation Solution Market Outlook, By Static Cold Storage (2021-2030) ($MN)
  • Table 137 Middle East & Africa Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2021-2030) ($MN)
  • Table 138 Middle East & Africa Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2021-2030) ($MN)
  • Table 139 Middle East & Africa Organ Preservation Solution Market Outlook, By Other Preservation Types (2021-2030) ($MN)
  • Table 140 Middle East & Africa Organ Preservation Solution Market Outlook, By Organ (2021-2030) ($MN)
  • Table 141 Middle East & Africa Organ Preservation Solution Market Outlook, By Kidneys (2021-2030) ($MN)
  • Table 142 Middle East & Africa Organ Preservation Solution Market Outlook, By Liver (2021-2030) ($MN)
  • Table 143 Middle East & Africa Organ Preservation Solution Market Outlook, By Lungs (2021-2030) ($MN)
  • Table 144 Middle East & Africa Organ Preservation Solution Market Outlook, By Heart (2021-2030) ($MN)
  • Table 145 Middle East & Africa Organ Preservation Solution Market Outlook, By Other Organs (2021-2030) ($MN)
  • Table 146 Middle East & Africa Organ Preservation Solution Market Outlook, By End User (2021-2030) ($MN)
  • Table 147 Middle East & Africa Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2021-2030) ($MN)
  • Table 148 Middle East & Africa Organ Preservation Solution Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 149 Middle East & Africa Organ Preservation Solution Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 150 Middle East & Africa Organ Preservation Solution Market Outlook, By Other End Users (2021-2030) ($MN)
目次
Product Code: SMRC24712

According to Stratistics MRC, the Global Organ Preservation Solution Market is accounted for $278.64 million in 2023 and is expected to reach $502.85 million by 2030 growing at a CAGR of 8.8% during the forecast period. Organ Preservation Solution has the ability to preserve organ viability during the crucial time between donation and transplantation, organ preservation solutions are essential to transplant medicine. The ideal preservation environment is provided by these specialized solutions, which are made to shield organs from ischemia damage. These solutions aid in preserving cellular integrity and preventing cellular swelling.

According to the estimates by the Centers for Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease. Per the CDC report issued in 2021, ~15% of people in the US suffer from chronic renal disease each year.

Market Dynamics:

Driver:

Growing numbers of organ transplant operations

The world's organ transplantation rate is increasing at an unstoppable rate due to an increase in chronic diseases that cause organ failure as well as improvements in surgical methods and immunosuppressive medications. Additionally, the growing demand highlights how vital organ preservation solutions are to the survival and success of transplant operations, which in turn drives ongoing research and development endeavors to enhance and optimize these solutions for a variety of organ kinds.

Restraint:

Limited effectiveness of existing preservation methods

The viability of some organs may be limited by some current organ preservation methods, even with advancements in the field, especially when done for prolonged periods of time. Developing universally effective solutions is challenging due to the complexity of various organs and their distinct physiological requirements. Furthermore, a comprehensive grasp of the preservation requirements unique to each organ and continuous research to improve the effectiveness of current formulations are necessary to address this constraint.

Opportunity:

Technological developments in cryopreservation

The organ preservation market is expected to grow as long as cryopreservation technology continues to progress. The prolongation of organ preservation periods and the enhancement of long-term storage feasibility can be possible through advancements in cryoprotectants and freezing techniques. Moreover, this can lead to more flexible organ transplant scheduling and improved logistical management.

Threat:

Inadequate standardization of preservation procedures

The lack of established procedures for organ preservation creates obstacles and risks for the industry. Disparate protocols among healthcare facilities and geographical areas could impede communication and lead to inconsistent preservation results. Additionally, the establishment of widely recognized standards is essential to guaranteeing the dependability and efficiency of organ preservation techniques.

COVID-19 Impact:

The market for organ preservation has seen a variety of effects from the COVID-19 pandemic. Organ transplantation procedures have been impacted, which has resulted in a decrease in transplant volumes. These factors include disruptions in healthcare systems, logistical difficulties, and a shift in priorities towards managing the pandemic. Organ transplantation has been hampered by lockdowns, travel restrictions, and limited access to healthcare. Furthermore, research and development for organ preservation solutions have also seen changes in response to the financial strain on healthcare budgets and resources.

The University of Wisconsin Solution (UW) segment is expected to be the largest during the forecast period

It is projected that the University of Wisconsin Solution (UW) segment will command the largest market share. Organ transplants for the kidney, liver, and pancreas are frequently performed using the UW solution, an extremely effective and adaptable organ preservation medium. Because of its osmotic pressure, balanced electrolyte composition, and capacity to reduce cellular edema, it is the recommended option for organ preservation during the crucial time between organ procurement and transplantation. Moreover, its broad acceptance can be attributed to its successful transplantation outcomes, long history of clinical use, and track record of preserving organ viability.

The Specialty Clinics segment is expected to have the highest CAGR during the forecast period

The market for organ preservation is growing at the highest CAGR in specialty clinics. The growth of specialty clinics devoted to organ transplantation and preservation is facilitated by the trend toward more specialized healthcare services as well as the rising need for targeted, patient-centered care. Pre-transplant evaluations, organ preservation techniques, and post-transplant care are just a few of the extensive services provided by these clinics. Additionally, patients are seeking the expertise of specialized clinics, which often offer more efficient and personalized care than traditional hospitals, due to the increasing prevalence of organ failure conditions and advancements in transplantation techniques.

Region with largest share:

In the market for organ preservation solutions, North America holds the largest share. Numerous factors contribute to this dominance, such as a well-developed healthcare system, a high frequency of organ transplant procedures, and ongoing advancements in medical science and technology. Furthermore, the region is at the forefront of the industry because of its strong regulatory environment, large R&D expenditure, and proactive adoption of cutting-edge healthcare solutions.

Region with highest CAGR:

In the market for organ preservation solutions, the Asia-Pacific region has the highest CAGR. A number of factors, including an increase in the prevalence of organ failure conditions, public awareness of organ transplantation, and advancements in healthcare infrastructure, are driving this region's rapid growth. Furthermore, the growing market share in the Asia-Pacific region can be attributed to the growing emphasis on medical tourism as well as advancements in organ preservation techniques.

Key players in the market:

Some of the key players in Organ Preservation Solution market include Paragonix Technologies, Inc, Organox Limited, Transmedics, Inc., Bridge to Life Ltd, Transplant Biomedicals, Accord Healthcare Inc., Waters Medical Systems LLC, Preservation Solutions, Inc. and Xvivo Perfusion AB.

Key Developments:

In August 2023, US-based commercial medical group TransMedics Group announced the completion of the full acquisition of Summit Aviation, a premier US charter flight operator. The acquisition establishes TransMedics Aviation as the first integrated national provider of air logistics dedicated exclusively to organ transplantation in the US.

In July 2023, Organox Ltd. raised £25 million in a funding round that will allow the company to expand its operations in the U.S. on the back of significantly increasing demand from transplant centers, Oern Stuge, executive chairman, at Organox told BioWorld. The Oxford, U.K.-based company which makes systems to preserve and transport livers for transplant is also preparing for its eventual listing on Nasdaq, he added.

In March 2023, Paragonix Technologies, Inc., a leading organ transplant company, today announced that it has secured $24 million in Series B funding, led by Signet Healthcare Partners. This growth investment will bolster Paragonix Technologies' commercial footprint, including its ongoing extension of clinical service offerings and inventory expansion, and will enable the Company to further advance transplant innovations.

Solutions Covered:

  • University of Wisconsin Solution (UW)
  • Custodiol HTK Solution
  • Perfadex Solution
  • Steen Solution
  • Celsior Solution
  • Hypothermosol Solution
  • Other Solutions

Preservation Types Covered:

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
  • Other Preservation Types

Organs Covered:

  • Kidneys
  • Liver
  • Lungs
  • Heart
  • Other Organs

End Users Covered:

  • Organ Transplant Centers
  • Hospitals
  • Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Organ Preservation Solution Market, By Solution

  • 5.1 Introduction
  • 5.2 University of Wisconsin Solution (UW)
  • 5.3 Custodiol HTK Solution
  • 5.4 Perfadex Solution
  • 5.5 Steen Solution
  • 5.6 Celsior Solution
  • 5.7 Hypothermosol Solution
  • 5.8 Other Solutions

6 Global Organ Preservation Solution Market, By Preservation Type

  • 6.1 Introduction
  • 6.2 Static Cold Storage
  • 6.3 Hypothermic Machine Perfusion
  • 6.4 Normothermic Machine Perfusion
  • 6.5 Other Preservation Types

7 Global Organ Preservation Solution Market, By Organ

  • 7.1 Introduction
  • 7.2 Kidneys
  • 7.3 Liver
  • 7.4 Lungs
  • 7.5 Heart
  • 7.6 Other Organs

8 Global Organ Preservation Solution Market, By End User

  • 8.1 Introduction
  • 8.2 Organ Transplant Centers
  • 8.3 Hospitals
  • 8.4 Specialty Clinics
  • 8.5 Other End Users

9 Global Organ Preservation Solution Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Paragonix Technologies, Inc
  • 11.2 Organox Limited
  • 11.3 Transmedics, Inc.
  • 11.4 Bridge to Life Ltd
  • 11.5 Transplant Biomedicals
  • 11.6 Accord Healthcare Inc.
  • 11.7 Waters Medical Systems LLC
  • 11.8 Preservation Solutions, Inc.
  • 11.9 Xvivo Perfusion AB